ARG1

arginase 1

Basic information

Region (hg38): 6:131470832-131584332

Links

ENSG00000118520NCBI:383OMIM:608313HGNC:663Uniprot:P05089AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hyperargininemia (Definitive), mode of inheritance: AR
  • hyperargininemia (Definitive), mode of inheritance: AR
  • hyperargininemia (Strong), mode of inheritance: AR
  • hyperargininemia (Definitive), mode of inheritance: AR
  • hyperargininemia (Supportive), mode of inheritance: AR
  • hyperargininemia (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
HyperargininemiaARBiochemical; PharmacogenomicDietary and medical therapy (eg, with low-protein, arginine restricted diet, sodium benzoate, as well as with enzyme replacement), may be beneficial; Individuals with more severe and earlier presentations (similar to that of other urea cycle disorders) have been reported, and may benefit from similar care to prevent and acute sequelae; Individuals with urea cycle disorders may demonstrate sensitivity to certain agents, such as valproateBiochemical; Neurologic1124944; 839368; 624188; 6422160; 3104676; 2913054; 2311630; 2365823; 2246859; 2291040; 8474825; 7649538; 9762606; 12640389; 16963300; 19052914; 19381865; 21229317; 21802329; 21310339; 22959135; 22928720; 22633632; 25135652; 29726057; 36049366

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ARG1 gene.

  • Arginase deficiency (53 variants)
  • not provided (6 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARG1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
139
clinvar
2
clinvar
141
missense
9
clinvar
11
clinvar
117
clinvar
4
clinvar
141
nonsense
6
clinvar
8
clinvar
1
clinvar
1
clinvar
16
start loss
2
clinvar
2
frameshift
30
clinvar
24
clinvar
3
clinvar
57
inframe indel
1
clinvar
7
clinvar
8
splice donor/acceptor (+/-2bp)
8
clinvar
15
clinvar
23
splice region
6
19
1
26
non coding
8
clinvar
62
clinvar
15
clinvar
85
Total 54 60 136 206 17

Highest pathogenic variant AF is 0.0000197

Variants in ARG1

This is a list of pathogenic ClinVar variants found in the ARG1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-131572958-G-A Likely benign (Jul 27, 2018)1201077
6-131573213-A-G Arginase deficiency Uncertain significance (Jan 13, 2018)355314
6-131573218-C-T Arginase deficiency Benign (Jun 29, 2018)355315
6-131573262-A-C Arginase deficiency Uncertain significance (May 19, 2022)355316
6-131573284-T-C Arginase deficiency Pathogenic/Likely pathogenic (Feb 24, 2022)555971
6-131573285-G-A Arginase deficiency Pathogenic/Likely pathogenic (Oct 15, 2023)645245
6-131573286-A-G Arginase deficiency Uncertain significance (Dec 31, 2021)1945671
6-131573287-G-T Arginase deficiency Uncertain significance (Nov 27, 2021)2007103
6-131573288-C-T Arginase deficiency Likely benign (Nov 15, 2023)1529356
6-131573289-G-A Arginase deficiency Uncertain significance (Jul 12, 2022)1493188
6-131573289-G-C Arginase deficiency Uncertain significance (Oct 24, 2022)1042824
6-131573291-C-G Arginase deficiency Likely benign (May 10, 2023)2863052
6-131573296-C-G Arginase deficiency Uncertain significance (Jul 25, 2022)1979830
6-131573297-C-G Likely benign (Nov 27, 2018)795190
6-131573298-A-G Arginase deficiency Uncertain significance (Sep 06, 2022)1517542
6-131573301-A-C Arginase deficiency Uncertain significance (Aug 19, 2022)1362705
6-131573304-A-G Arginase deficiency Uncertain significance (Oct 03, 2023)1060640
6-131573305-T-A Arginase deficiency • not specified Conflicting classifications of pathogenicity (May 14, 2024)1044951
6-131573310-AT-A Arginase deficiency Likely pathogenic (Jun 16, 2020)992369
6-131573312-T-C Arginase deficiency Likely benign (Aug 04, 2023)2007945
6-131573314-T-C Arginase deficiency Pathogenic/Likely pathogenic (Mar 03, 2024)2393
6-131573324-T-A Arginase deficiency Likely benign (Feb 01, 2024)738539
6-131573324-T-G Arginase deficiency Likely benign (Nov 27, 2023)2713318
6-131573329-CA-C Arginase deficiency Pathogenic (Mar 21, 2022)1074774
6-131573330-A-C Arginase deficiency Likely benign (Jul 26, 2018)763789

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ARG1protein_codingprotein_codingENST00000356962 811189
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0003590.9571256910531257440.000211
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.05601761780.9880.000008622125
Missense in Polyphen7477.9940.94879913
Synonymous0.01436767.10.9980.00000355685
Loss of Function1.81815.70.5088.27e-7194

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001310.00131
Ashkenazi Jewish0.0001990.000198
East Asian0.0001090.000109
Finnish0.00004630.0000462
European (Non-Finnish)0.0001060.000105
Middle Eastern0.0001090.000109
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Key element of the urea cycle converting L-arginine to urea and L-ornithine, which is further metabolized into metabolites proline and polyamides that drive collagen synthesis and bioenergetic pathways critical for cell proliferation, respectively; the urea cycle takes place primarily in the liver and, to a lesser extent, in the kidneys. {ECO:0000305}.;
Disease
DISEASE: Argininemia (ARGIN) [MIM:207800]: A rare autosomal recessive disorder of the urea cycle. Arginine is elevated in the blood and cerebrospinal fluid, and periodic hyperammonemia occurs. Clinical manifestations include developmental delay, seizures, mental retardation, hypotonia, ataxia and progressive spastic quadriplegia. {ECO:0000269|PubMed:1463019, ECO:0000269|PubMed:22959135, ECO:0000269|PubMed:23859858, ECO:0000269|PubMed:7649538}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Arginine and proline metabolism - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Arginine biosynthesis - Homo sapiens (human);Argininemia;Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Citrullinemia Type I;Carbamoyl Phosphate Synthetase Deficiency;Argininosuccinic Aciduria;Urea Cycle;Prolinemia Type II;Prolidase Deficiency (PD);Ornithine Transcarbamylase Deficiency (OTC Deficiency);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);Spinal Cord Injury;Amino Acid metabolism;Urea cycle and metabolism of amino groups;Neutrophil degranulation;Metabolism of polyamines;Metabolism of amino acids and derivatives;Innate Immune System;Immune System;Metabolism;ATF-2 transcription factor network;urea cycle;Arginine Proline metabolism;IL4-mediated signaling events;Urea cycle (Consensus)

Recessive Scores

pRec
0.431

Intolerance Scores

loftool
0.321
rvis_EVS
-0.25
rvis_percentile_EVS
35.75

Haploinsufficiency Scores

pHI
0.656
hipred
N
hipred_score
0.276
ghis
0.581

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.984

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Arg1
Phenotype
homeostasis/metabolism phenotype; hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; immune system phenotype;

Gene ontology

Biological process
urea cycle;liver development;positive regulation of endothelial cell proliferation;adaptive immune response;arginine catabolic process;aging;response to herbicide;response to manganese ion;response to zinc ion;response to selenium ion;regulation of L-arginine import;response to amine;arginine catabolic process to ornithine;lung development;collagen biosynthetic process;response to vitamin A;response to vitamin E;negative regulation of T cell proliferation;defense response to protozoan;response to amino acid;neutrophil degranulation;innate immune response;negative regulation of activated T cell proliferation;response to cadmium ion;response to axon injury;response to methylmercury;mammary gland involution;maternal process involved in female pregnancy;negative regulation of interferon-gamma-mediated signaling pathway;protein homotrimerization;cellular response to hydrogen peroxide;positive regulation of neutrophil mediated killing of fungus;cellular response to lipopolysaccharide;cellular response to interleukin-4;cellular response to glucagon stimulus;cellular response to dexamethasone stimulus;cellular response to transforming growth factor beta stimulus;negative regulation of T-helper 2 cell cytokine production
Cellular component
extracellular region;extracellular space;nucleus;cytoplasm;mitochondrial outer membrane;cytosol;azurophil granule lumen;specific granule lumen;neuron projection;neuronal cell body
Molecular function
arginase activity;protein binding;manganese ion binding